During your teleconsultation, our clinician will help choose the best option for your needs and insurance situation
In the United States, prescribing information for all medications licensed for obesity that act on the CNS, including the GLP-1RAs liraglutide 3 mg (Saxenda) and semaglutide 2.4 mg (Wegovy), must include the recommendation of monitoring for depression and suicidal ideation 231
The company is headquartered in Alphen aan den Rijn, Netherlands
Other recognized adverse effects include injection site reactions, fatigue, headache, and dizziness
doi:10.1001/jamanetworkopen.2024.3474 Semaglutides efficacy in achieving weight loss for those with HIV (SWIFT).
Wegovy (semaglutide 2.4 mg) approved in the US for the treatment of MASH Novo Nordisk Novo Nordisk announced that the FDA has approved an additional indication for Wegovy (semaglutide 2.4 mg) based on a supplemental New Drug Application (sNDA) for treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced calorie diet and increased physical activity
